Sidoti Csr Has Positive Forecast for Balchem Q1 Earnings

Balchem Co. (NASDAQ:BCPC) – Research analysts at Sidoti Csr boosted their Q1 2025 earnings estimates for shares of Balchem in a note issued to investors on Tuesday, February 25th. Sidoti Csr analyst D. Harriman now anticipates that the basic materials company will post earnings of $1.25 per share for the quarter, up from their previous estimate of $1.19. The consensus estimate for Balchem’s current full-year earnings is $4.64 per share. Sidoti Csr also issued estimates for Balchem’s Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.27 EPS, FY2025 earnings at $5.10 EPS, Q1 2026 earnings at $1.33 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.38 EPS, Q4 2026 earnings at $1.33 EPS and FY2026 earnings at $5.40 EPS.

Balchem (NASDAQ:BCPC) last issued its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%.

BCPC has been the topic of several other reports. HC Wainwright reiterated a “buy” rating and set a $190.00 price target on shares of Balchem in a research note on Monday. StockNews.com cut Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday.

Balchem Stock Down 0.5 %

BCPC stock opened at $172.69 on Wednesday. The stock has a market cap of $5.61 billion, a P/E ratio of 43.94, a PEG ratio of 4.41 and a beta of 0.69. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company’s 50 day moving average is $162.13 and its two-hundred day moving average is $169.46.

Institutional Trading of Balchem

A number of large investors have recently bought and sold shares of the business. Mackenzie Financial Corp grew its stake in shares of Balchem by 2.2% in the 4th quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company’s stock valued at $626,000 after purchasing an additional 84 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in Balchem in the 4th quarter valued at $3,246,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Balchem by 9.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 91,742 shares of the basic materials company’s stock valued at $14,953,000 after buying an additional 8,091 shares during the period. Voloridge Investment Management LLC raised its position in Balchem by 41.0% during the 4th quarter. Voloridge Investment Management LLC now owns 26,178 shares of the basic materials company’s stock worth $4,267,000 after buying an additional 7,608 shares during the last quarter. Finally, Vident Advisory LLC lifted its stake in shares of Balchem by 6.0% in the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company’s stock worth $232,000 after acquiring an additional 80 shares during the period. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were issued a $0.87 dividend. This represents a dividend yield of 0.4%. This is a boost from Balchem’s previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. Balchem’s payout ratio is presently 22.14%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.